Details for New Drug Application (NDA): 212676
✉ Email this page to a colleague
The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are eight drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 212676
Tradename: | TRANEXAMIC ACID |
Applicant: | Provepharm Sas |
Ingredient: | tranexamic acid |
Patents: | 0 |
Pharmacology for NDA: 212676
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 212676
Suppliers and Packaging for NDA: 212676
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212676 | ANDA | A-S Medication Solutions | 50090-5072 | 50090-5072-0 | 10 mL in 1 VIAL, SINGLE-DOSE (50090-5072-0) |
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 212676 | ANDA | Provepharm Inc. | 81284-611 | 81284-611-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (81284-611-10) / 10 mL in 1 VIAL, SINGLE-DOSE (81284-611-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
Approval Date: | Jul 17, 2019 | TE: | AP | RLD: | No |
Complete Access Available with Subscription